Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

ZIPS Study - Zip Incision aPproximation vs. Suture (ZIPS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02213510
Recruitment Status : Completed
First Posted : August 11, 2014
Results First Posted : May 30, 2016
Last Update Posted : May 30, 2016
Sponsor:
Collaborator:
ZipLine Medical Inc.
Information provided by (Responsible Party):
Ulrika Birgersdotter-Green, University of California, San Diego

Brief Summary:
ZipLine Medical, Inc. has developed a novel, non-invasive skin closure device called "Zip Surgical Skin Closure" to replace sutures, staples and glue for closure of the skin layer for surgical incisions or laceration repair. The study will be comparing the Zip Surgical Skin Closure to standard sutures in patients undergoing cardiovascular implantable electronic device (CIED) procedures on outcomes including closure time, cosmetic appearance of resulting scar, and overall cosmetic appearance of scar. The study will be following participants for 3 months following CIED procedure.

Condition or disease Intervention/treatment Phase
Wound Cardiac Arrhythmia Device: Zip Surgical Skin Closure Device Device: Standard Suture Closure Not Applicable

Detailed Description:

ZipLine Medical, Inc. has developed a novel, non-invasive skin closure device called "Zip Surgical Skin Closure" to replace sutures, staples and glue for closure of the skin layer for surgical incisions or laceration repair. The device is designed to provide closure speed superior to sutures, while resulting in a suture-like cosmetic outcome.The ZIPS study is a randomized, clinical trial comparing outcomes of procedures that use the Zip Surgical Skin Closure device with the outcomes of procedures that use stitches. The Zip Surgical Skin Closure is not an investigational device and is currently used in hospital across the United States. The Zip Surgical Skin Closure is a non-invasive (in other words, does not pierce the skin or enter into the wound) device to hold skin closed while healing can occur. It adheres to the skin close to the incision and uses adjustable straps to hold the incision closed. It is typically worn on the skin for 7-14 days and is removed by peeling from the skin. Patients will be randomized to either Zip Surgical Skin Closure or sutures, in addition to dissolvable sutures for the deeper layers, for surgical procedures for cardiovascular implantable electronic devices (CIED) i.e. pacemakers or defibrillators. Both of these closure techniques are considered standard of care at this facility and are not themselves experimental. However, the goal of this experimental study is to see if there are any significant differences between the two closure methods, in a controlled study environment.

Since the Zip Surgical Skin Closure device is relatively new to the market, there is a limited amount of information available describing the experience of patients and doctors using the device. In this study, the investigators will be looking to compare the Zip Surgical Skin Closure and stitches methods for the time necessary for the surgeon to close the incision, cosmetic appearance of the resulting scar, and satisfaction of you and your surgeon. The investigators will also be monitoring both study groups for occurrence of any adverse (unfavorable) events. Patients will be followed for a total of 3 months for this study. All study visits align with standard of care follow up for post-implantation of CIED. Non-identifiable pictures will be obtained of the scar during follow up and both patients and surgeons will complete questionnaires indicating their experience and satisfaction with the either skin closure method.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: A Prospective, Non-blinded, Randomized Controlled Post-market Study Designed to Compare the Use of the Zip Surgical Skin Closure Device Versus Conventional Sutures for Skin Closure in Subjects Who Undergo a CIED Procedure.
Study Start Date : August 2014
Actual Primary Completion Date : June 2015
Actual Study Completion Date : June 2015

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Zip Surgical Skin Closure device
The Zip Surgical Skin Closure device is a single use, sterile medical device that replaces sutures, staples, and glue for closure of the skin layer for surgical incisions or laceration repair. The device will applied by the surgeon at the end of the CIED procedure and be worn until the two week post-operative wound check.
Device: Zip Surgical Skin Closure Device
The Zip Surgical Skin Closure device is a single use, sterile medical device that replaces sutures, staples, and glue for closure of the skin layer for surgical incisions or laceration repair. The device will applied by the surgeon at the end of the CIED procedure and be worn until the two week post-operative wound check.
Other Name: Wound closure device

Active Comparator: Standard Suture Closure
The surgeon will perform standard suture closure for the skin layer following CIED procedure.
Device: Standard Suture Closure
The surgeon will perform standard suture closure for the skin layer following CIED procedure.




Primary Outcome Measures :
  1. Overall Closure Time [ Time Frame: 2 weeks ]
    Duration of time starting when suture needle (control) or Zip device touches the skin until final suture knot is cut or Zip device application is complete (e.g., top liner is removed.)

  2. Wound Healing as Determined by the CVAS (Cosmetic Visual Analogue Scale) [ Time Frame: 3 Months ]
    Based on photographs taken of scars taken at 3 months following CIED procedure. The CVAS scale is measured from 0mm (representing best scar) to 100 mm (representing worst scar).


Secondary Outcome Measures :
  1. Surgeon Wound Evaluation Scale (WES) [ Time Frame: 2 weeks ]
    At 2 weeks post-procedure, the Wound Evaluation Scale was measured. The scale is based from 0 (representing normal skin) to 100 (representing a poor scar).

  2. Surgeon Evaluation Based on the Wound Evaluation Scale (WES) [ Time Frame: 3 Months ]

    The surgeon will complete an assessment of the following:

    1. Closure Method Satisfaction
    2. Scar Satisfaction
    3. Wound Healing as judged by Wound Evaluation Scale

    Scale rated on 1 (least favorable) to 6 (most favorable)

    Please note that only 18 patients were evaluated (of 19) in the Standard Suture Closure due to one patient withdrawing from the trial.


  3. Surgeon Satisfaction With Scar [ Time Frame: 3 months ]

    At 3 months post-procedure, the surgeon evaluated their satisfaction on a scale from 1 to 5, 5 being the least favorable.

    Please note that only 18 patients were evaluated (of 19) in the Standard Suture Closure due to one patient withdrawing from the trial.


  4. Patient Comfort [ Time Frame: 2 weeks ]
    At 2 weeks post-procedure, patient comfort was evaluated with a scale 1 (most favorable) to 5 (least favorable).

  5. Patient Satisfaction With Scar [ Time Frame: 3 months ]

    Patient will complete questionnaires that includes assessments of the following:

    1. Pain
    2. Closure Method Comfort
    3. Closure Method Satisfaction
    4. Scar Satisfaction

    Scar Satisfaction was measured on a scale from 1 (most satisfied) to 5 (least satisfied)

    Please note that only 18 patients were evaluated (of 19) in the Standard Suture Closure due to one patient withdrawing from the trial.


  6. Patient Rating of Scar [ Time Frame: 3 months ]

    At 3 months post-procedure, patients were asked to rate their scar. Scale was measured from 0 (best scar) - 10 (worst scar)

    Please note that only 18 patients were evaluated (of 19) in the Standard Suture Closure due to one patient withdrawing from the trial.


  7. Patient Incision Pain [ Time Frame: 1 day (discharge) ]
    At the discharge visit, patients evaluated their level of pain at the incision site based on a scale 1 (least pain) through 10 (worst pain).

  8. Patient Incision Pain [ Time Frame: 2 weeks ]
    At 2 week post-procedure, incision pain was evaluated on a scale 0 to 10 (worst pain).

  9. Patient Incision Pain [ Time Frame: 3 months ]
    Incision pain experienced by the patient was evaluated at 3 months post-procedure. This was evaluated on a scale of 0 (least pain) to 10 (worst pain).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Patients 18 years of age and older;
  2. Patients requiring suture closure for epidermal closure (after placement of cardiac implantable electronic devices; including de novo and re implant generator changes);
  3. Patients willing and able to complete study protocol
  4. Life expectancy greater than 1 year

Exclusion Criteria:

  1. Known bleeding disorder not caused by medication;
  2. Known personal or family history of keloid formation or scar hypertrophy;
  3. Known allergy or hypersensitivity to non-latex skin adhesives;
  4. Atrophic skin deemed clinically prone to blistering;
  5. Any skin disorder affecting wound healing;
  6. Any other condition that in the opinion of the investigator would make a particular subject unsuitable for this study.
  7. Pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02213510


Locations
Layout table for location information
United States, California
UCSD Sulpizio Cardiovascular Center
La Jolla, California, United States, 92037
Sponsors and Collaborators
University of California, San Diego
ZipLine Medical Inc.
Investigators
Layout table for investigator information
Principal Investigator: Ulrika Birgersdotter-Green, MD University of California, San Diego

Additional Information:
Layout table for additonal information
Responsible Party: Ulrika Birgersdotter-Green, Clinical Professor, University of California, San Diego
ClinicalTrials.gov Identifier: NCT02213510     History of Changes
Other Study ID Numbers: 140718
First Posted: August 11, 2014    Key Record Dates
Results First Posted: May 30, 2016
Last Update Posted: May 30, 2016
Last Verified: May 2016
Keywords provided by Ulrika Birgersdotter-Green, University of California, San Diego:
pacemaker
implantable cardioverter defibrillator
ICD
surgical wound closure
sutures
Zipline
Zips
CIED
cardiovascular implantable electronic devices
arrhythmia
Additional relevant MeSH terms:
Layout table for MeSH terms
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes